Iovance Biotherapeutics logo Clinical Trials

Explore investigational TIL cell therapy clinical trials

Non-small cell lung cancer trial icon

IOV-LUN-202:

Non-Small Cell Lung Cancer (NSCLC)

A Phase 2, multicenter trial in patients with metastatic NSCLC with disease progression following chemoimmunotherapy

View trial
Advanced melanoma trial icon

TILVANCE-301:

Advanced Melanoma

A Phase 3, multicenter trial in patients with unresectable or metastatic melanoma with no prior therapy for metastatic disease

View trial
Non-small cell lung cancer trial icon

IOV-IL2-101:

Advanced Melanoma

A Phase 1/2, open-label trial of modified interleukin-2 fusion protein (for supporting the activity of lifileucel) in patients with melanoma that was previously treated, unresectable (cannot be treated by surgery), or metastatic (has spread to a different part of the body) who will receive treatment with lifileucel

View trial
Endometrial cancer trial icon

IOV-END-201:

Endometrial Cancer

A Phase 2 trial assessing lifileucel in patients with advanced endometrial cancer

View trial

TIL=tumor infiltrating lymphocytes.

This website is intended for a U.S. audience. TIL cell therapy is not yet approved by any regulatory or health agency for the investigational uses described in this website. This website is for educational purposes only and is not intended to replace discussions with a healthcare professional.